PROVIDER PROFILE · NPI 1104904960

Mark TanakaM.D.

PRACTICEKAISER FOUNDATION HOSPITALSSee all providers at this practice →

Emergency MedicineSan Leandro, CAI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$758

Distinct drugs

Brand share

71.8%

Top prescribed drugs

Ondansetron33 claims

Moxifloxacin Hcl16 claims

Ofloxacin13 claims

Hydrocodone/Acetaminophen12 claims

Doxycycline Monohydrate11 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 050777

Hospital

REFERRAL NETWORK

Where Mark Tanaka's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 2 outbound destinations.

Receives referrals from

Inbound — who sends patients here

No inbound pairs above the suppression threshold.

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
KAISER FOUNDATION HOSPITALS	19	32
KAISER FOUNDATION HOSPITALS	13	31

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history